Boehringer Ingelheim Vetmedica, Inc. (BIVI) once again invites public and private researchers studying equine infectious diseases to submit proposals for the 2016 Equine Research Awards.
“BIVI knows that the future of equine health lies in identifying new disease treatment and prevention methods, which is why we support the research awards,” said Steve Grubbs, DVM, PhD, DACVIM, the BIVI equine technical manager. “Through this program, we are committed to helping advance the understanding, diagnosis and prevention of equine diseases.”
Proposals must address the following focus areas for consideration:
- Practical application and ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease(s)
- Disease(s) can be bacterial or viral etiologies
Veterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine infectious diseases. BIVI will give a total of $75,000 in five individual $15,000 awards to fund selected studies.
Proposals must be submitted by Sept. 15, 2016, and will be reviewed by an independent equine research review board composed of industry professionals, including practicing equine veterinarians and researchers. Awards will be determined based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the yearlong studies. The awards will be announced during the 2016 American Association of Equine Practitioners Annual Convention in Orlando, Florida.
To participate in the research awards program, submit a proposal, cover letter, curriculum vitae and two letters of recommendation by Sept. 15, 2016, to:
Boehringer Ingelheim Vetmedica, Inc.
Attn: Steve Grubbs, DVM, Ph.D., DACVIM
The Advancement in Equine Research Award
3902 Gene Field Road
St. Joseph, MO 64506 USA
The BIVI Equine Research Awards were launched in 2011 to support veterinary research that results in practical applications for or insights into important equine infectious diseases and improves the quality of life for all horses. More than $375,000 has been donated to date for research into these diseases, which include equine influenza, equine rhinitis virus, coronavirus and equine inflammatory airway diseases.
For more information and complete submission instructions, please visit us at www.equinediseaseresearch.com.
Boehringer Ingelheim Vetmedica, Inc., (BIVI) develops, manufactures and markets novel and innovative solutions for the prevention and treatment of disease in the cattle, equine, pet and swine markets. BIVI is the fifth largest animal health company in the U.S. and is a part of the global Boehringer Ingelheim Animal Health GmbH. Our U.S. headquarters are located within the KC Animal Health Corridor in St. Joseph, Mo., with other sites in Ames, Fort Dodge and Sioux Center, Iowa. We have 2,000 employees unleashing their collective passion to keep animals healthy every day. With more than 3,800 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about 1.4 billion euros in 2015. In our research-driven Animal Health business, Boehringer Ingelheim continually invests more than 11% of net sales of the Animal Health business in R&D. Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects through, for example, the initiative “Making More Health” while also caring for employees. Respect, equal opportunity and reconciling career and family form the foundation of mutual cooperation. The company also focuses on environmental protection and sustainability in everything it does. For more information, please visit www.bi-vetmedica.com.